Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

GYKI-16084 improves symptoms in benign prostatic hyperplasia

May 19, 2006

SOU-001 development discontinued at Sosei

May 17, 2006

Threshold changes TH-070 development program

May 16, 2006

Elocalcitol shows efficacy in overactive bladder phase II study

May 15, 2006

Urief launched in Japan for urinary disturbance associated with enlarged prostate

May 11, 2006

Bayer patent describes therapeutic agents for urinary incontinence

May 10, 2006

Phase IIb studies of bremelanotide in erectile dysfunction complete enrollment

May 8, 2006

Ilypsa grants Astellas Japanese rights to ILY-101

May 2, 2006

Safetek to develop new selective muscarinic receptor antagonist for OAB

April 28, 2006

Vaprisol launched for treatment of euvolemic hyponatremia

April 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...